Skip to content

A program of International Vaccine Access Center by Johns Hopkins Bloomberg School of Public Health

Value of Immunization Compendium of Evidence

Home
Evidence Briefs
Knowledge Hub
Advocacy
Vaccine Resources
About VoICE

Health gains and financial protection from pneumococcal vaccination and pneumonia treatment in Ethiopia: Results from an extended cost-effectiveness analysis

Post navigation

← Pneumococcal carriage at age 2 months is associated with growth deficits at age 6 months among infants in South India

Human Papillomavirus vaccination in HIV-infected women: need for increased coverage →

VoICE is a project of the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health, and is made possible with support from the Bill & Melinda Gates Foundation. We thank the many partners who have contributed their time, energy and expertise to VoICE.

Learn More About IVAC
Contact Us

© 2024 The International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health. All rights reserved

Translation Disclaimer